About us Our members Our work Our governance Become a sponsor

Our members

The CLL IC Taskforce is driven by its members from around the globe. Membership is voluntary and open to all. To read more about our governance, please refer to the Terms of Reference on our governance page.

Our Steering Committee

Chair

• Nick York: Patient Engagement Officer, Leukaemia Care and CLLAN Steering Committee Member and Chair Emeritus

Members

• Prof Stephen Opat: Co-chair of the Advocacy Working Group
•  Jana Pelouchova: Co-chair of the Advocacy Working Group
• Prof Paul Moss: Professor and Deputy Head, College of Medical and DentalSciences, University of Birmingham
• Prof John Seymour: Director of the Haematology Department, PeterMacCallum Cancer Centre & the Royal Melbourne Hospital
• Apendavyo Mshana: Founder, CLL Patient Support Group Tanzania;Executive Secretary, Blood Cancer Foundation of Tanzania
• Lorna Warwick: CEO, Lymphoma Coalition
• Andrielle Yost: Associate Director, Public Sector Engagement, The MaxFoundation
•  Prof Norah Akinola: Haematologist, Department of Haematology and BloodTransfusion, Obafemi Awolowo University and Teaching Hospitals Complex,Ile-Ife
• Deborah Henderson OAM: Director, Henderson Media Group
• Prof Paolo Ghia: President, ERIC
• Raymond Vles: Chair, CLL Canada
• Dr Catherine Moura: CEO, Abrale – Brazilian Lymphoma and LeukemiaAssociation and Abrasta – Brazilian Association of Thalassemia
• Pierre Aumont: Administrator, ELLyE and Member and Vice Chair, CLLANSteering Committee
• Megan Yuan: AstraZeneca
• Helena Hjertonsson: Takeda

Our Working Groups

Advocacy Working Group

Co-chairs:

• Prof. Stephen Opat: Director, Clinical Haematology, Monash Health;Founder & chair, Australasian Lymphoma and Related Diseases Registry
• Jana Pelouchova: Founder and Chair, Diagnoza Leukemia

Members:

• Raymond Vles: Chair of Board, CLL Canada
• John Greensmyth: Deputy Chair, CLL Support UK
• Rita Christensen: Chairperson, LyLe
• Jennifer Wilson: Senior Information Specialist, Blood Cancer United andCLLAN Steering Committee Member
• Pierre Aumont: Administrator, ELLyE and Member and Vice Chair, CLLANSteering Committee
• Jenny Zhang: House086
• Michael Rynne: Patient Advocate, CLL Ireland
• Bahija Gouimi: President, Association des Malades Atteints de Leucémies(AMAL)
•  Vandana Gupta: Founder, V Care FoundationApendavyo Mshana: Founder, CLL Patient Support Group Tanzania andExecutive Secretary, Blood Cancer Foundation Tanzania
• Dr Brian Koffman: Chief Medical Officer and Executive Vice President, CLLSociety Inc. and CLLAN Steering Committee Member Deborah Henderson: Director, Henderson Media Group
• Dr Catherine Moura: CEO, Abrale – Brazilian Lymphoma and Leukemia Association and Abrasta – Brazilian Association of Thalassaemia
• Prof Norah O. Akinola, FACP: Haematologist, Department of Haematologyand Blood Transfusion, Obafemi Awolowo University and Teaching HospitalsComplex, Ile-Ife
• Dr Christina Karamanidou: Postdoctoral Researcher, ERIC CERTH-INAB
• Natacha Bolaños: Head, Membership & Alliances, Lymphoma Coalition
• Megan Yuan: AstraZeneca
• Helena Hjertonsson: Takeda
• Jenni Mildon: Johnson&Johnson

Clinical Working Group

Co-chairs:

• Dr Helen Parry: Associate Professor, Institute of Immunology andImmunotherapy, University of Birmingham and Honorary Consultant, QueenElizabeth Hospital, Birmingham
• Dr Lydia Scarfò: Physician Scientist, B-Cell neoplasia unit, AssistantProfessor, Universita Vita-Salute San Raffaele

Members:

• Dr Helen Parry: Associate Professor, Institute of Immunology andImmunotherapy, University of Birmingham and Honorary Consultant, QueenElizabeth Hospital, Birmingham
• Dr Lydia Scarfò: Physician Scientist, B-Cell neoplasia unit, AssistantProfessor, Universita Vita-Salute San RaffaeleDr Versha Banerji: Associate Professor, Max Rady College of Medicine,University of Manitoba
• Dr Sanford Greenhouse: GP Prof Clemens-Martin Wendtner: Medical Director, Munich Clinic Schwabing
• Prof John Seymour: Director of the Haemotology Department, PeterMacCallum Cancer Centre & The Royal Melbourne Hospital
•  Dr Brian Koffman: Chief Medical Officer and Executive Vice President, CLLSociety Inc. and CLLAN Steering Committee Member
• Deborah Henderson: Director, Henderson Media Group Dr Catherine Moura: CEO, Abrale – Brazilian Lymphoma and LeukemiaAssociation and Abrasta – Brazilian Association of Thalassaemia
•  Jana Pelouchova: Founder and Chair, Diagnoza Leukemia Prof Norah O. Akinola, FACP: Haematologist, Department of Haematologyand Blood Transfusion, Obafemi Awolowo University and Teaching HospitalsComplex, Ile-Ife
• Prof Stephen Opat: Director, Clinical Haematology, Monash Health;Founder & chair, Australasian Lymphoma and Related Diseases Registry
• Dr Yervand Hakobyan: Head of Haematology and Transfusion MedicineDepartment, National Institute of Health, MH RA, Armenia
• Megan Yuan: AstraZeneca
• Stefan Wietek: Takeda

Our Secretariat

MHP Group provides secretariat to the CLL IC Task Force. In their role, the MHPGroup team provides overall management and coordination for the CLL IC Task Force, working in close collaboration with CLLAN, the Operational Committee and Working Groups. To find out more, contact: CLLICTaskforce@mhpgroup.com